MG
BSX icon

Mather Group’s Boston Scientific BSX Stock Holding History

Mather Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$443K Buy
10,381
+1,967
+23% +$107K ﹤0.01% 568
2026
Q1 		$528K Sell
8,414
-89
-1% -$7.12K 0.01% 472
2025
Q4 		$811K Buy
8,503
+757
+10% +$74.2K 0.01% 319
2025
Q3 		$756K Sell
7,746
-1
-0% -$104 0.01% 321
2025
Q2 		$832K Sell
7,747
-370
-5% -$37.4K 0.01% 296
2025
Q1 		$819K Sell
8,117
-924
-10% -$93K 0.01% 279
2024
Q4 		$807K Buy
9,041
+2,420
+37% +$213K 0.01% 266
2024
Q3 		$555K Sell
6,621
-1,033
-13% -$81.4K 0.01% 347
2024
Q2 		$524K Buy
7,654
+1,283
+20% +$93.9K 0.01% 405
2024
Q1 		$368K Sell
6,371
-722
-10% -$46.4K 0.01% 393
2023
Q4 		$410K Buy
7,093
+72
+1% +$3.84K 0.01% 389
2023
Q3 		$371K Buy
7,021
+386
+6% +$20.2K 0.01% 391
2023
Q2 		$359K Buy
+6,635
New +$347K 0.01% 419

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mather Group's BSX Position: Q2 2026 in Review

Mather Group increased its Boston Scientific (BSX) stake by 23% in Q2 2026, buying an estimated $107K and bringing the position to 10,381 shares worth $443K. The position accounts for ﹤0.01% of the portfolio, ranked #568.

Mather Group first reported a position in BSX in Q2 2023 and has held it in 13 quarters since. The position peaked at $832K in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Mather Group held 10,381 shares of Boston Scientific worth $443K as of Q2 2026.
  • Mather Group bought 1,967 Boston Scientific shares in Q2 2026, an estimated $107K.
  • Boston Scientific made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #568 holding.
  • Mather Group first reported a position in Boston Scientific in Q2 2023 and has held it in 13 quarters since.
  • Mather Group's Boston Scientific position peaked at $832K in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.